Sino Biopharmaceutical Limited

SEHK:1177 Voorraadrapport

Marktkapitalisatie: HK$60.1b

Sino Biopharmaceutical Dividenden en inkoop

Dividend criteriumcontroles 3/6

Sino Biopharmaceutical is een dividendbetalend bedrijf met een huidig rendement van 1.76% dat ruimschoots wordt gedekt door de winst.

Belangrijke informatie

1.8%

Dividendrendement

0.9%

Terugkoop Rendement

Totaal aandeelhoudersrendement2.7%
Toekomstig dividendrendement2.7%
Dividendgroei14.2%
Volgende betaaldatum dividendn/a
Ex-dividenddatumn/a
Dividend per aandeelHK$0.060
Uitbetalingsratio47%

Recente updates van dividend en inkoop

Recent updates

After Leaping 27% Sino Biopharmaceutical Limited (HKG:1177) Shares Are Not Flying Under The Radar

Oct 02
After Leaping 27% Sino Biopharmaceutical Limited (HKG:1177) Shares Are Not Flying Under The Radar

Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

Sep 02
Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

Are Investors Undervaluing Sino Biopharmaceutical Limited (HKG:1177) By 48%?

Jul 12
Are Investors Undervaluing Sino Biopharmaceutical Limited (HKG:1177) By 48%?

Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

May 21
Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

Sino Biopharmaceutical Limited's (HKG:1177) 27% Cheaper Price Remains In Tune With Earnings

Apr 21
Sino Biopharmaceutical Limited's (HKG:1177) 27% Cheaper Price Remains In Tune With Earnings

What Does The Future Hold For Sino Biopharmaceutical Limited (HKG:1177)? These Analysts Have Been Cutting Their Estimates

Apr 03
What Does The Future Hold For Sino Biopharmaceutical Limited (HKG:1177)? These Analysts Have Been Cutting Their Estimates

Sino Biopharmaceutical Limited's (HKG:1177) Intrinsic Value Is Potentially 34% Above Its Share Price

Mar 20
Sino Biopharmaceutical Limited's (HKG:1177) Intrinsic Value Is Potentially 34% Above Its Share Price

Sino Biopharmaceutical Limited's (HKG:1177) Shares May Have Run Too Fast Too Soon

Dec 18
Sino Biopharmaceutical Limited's (HKG:1177) Shares May Have Run Too Fast Too Soon

Does Sino Biopharmaceutical (HKG:1177) Have A Healthy Balance Sheet?

Dec 02
Does Sino Biopharmaceutical (HKG:1177) Have A Healthy Balance Sheet?

Sino Biopharmaceutical Limited (HKG:1177) Shares Could Be 41% Below Their Intrinsic Value Estimate

Nov 17
Sino Biopharmaceutical Limited (HKG:1177) Shares Could Be 41% Below Their Intrinsic Value Estimate

We Think Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt With Ease

Aug 30
We Think Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt With Ease

Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 50% Undervaluation?

May 26
Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 50% Undervaluation?

Sino Biopharmaceutical (HKG:1177) Has A Rock Solid Balance Sheet

Apr 20
Sino Biopharmaceutical (HKG:1177) Has A Rock Solid Balance Sheet

Is Sino Biopharmaceutical Limited (HKG:1177) Trading At A 38% Discount?

Feb 09
Is Sino Biopharmaceutical Limited (HKG:1177) Trading At A 38% Discount?

Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 41% Undervaluation?

Nov 11
Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 41% Undervaluation?

Sino Biopharmaceutical (HKG:1177) Seems To Use Debt Quite Sensibly

Oct 24
Sino Biopharmaceutical (HKG:1177) Seems To Use Debt Quite Sensibly

Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 46% Undervaluation?

Jul 08
Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 46% Undervaluation?

Is Sino Biopharmaceutical (HKG:1177) Using Too Much Debt?

Apr 28
Is Sino Biopharmaceutical (HKG:1177) Using Too Much Debt?

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: De dividendbetalingen van 1177 zijn de afgelopen 10 jaar volatiel geweest.

Groeiend dividend: De dividendbetalingen van 1177 zijn de afgelopen 10 jaar gestegen.


Dividendrendement versus markt

Sino Biopharmaceutical Dividendrendement versus markt
Hoe verhoudt 1177 dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (1177)1.8%
Markt onderkant 25% (HK)3.3%
Markt Top 25% (HK)8.1%
Gemiddelde industrie (Pharmaceuticals)3.8%
Analist prognose (1177) (tot 3 jaar)2.7%

Opmerkelijk dividend: Het dividend van 1177 ( 1.76% ) is niet noemenswaardig vergeleken met de onderste 25% van de dividendbetalers op de Hong Kong markt ( 3.32% ).

Hoog dividend: Het dividend 1177 ( 1.76% ) is laag vergeleken met de top 25% van dividendbetalers in de Hong Kong markt ( 8.06% ).


Winstuitkering aan aandeelhouders

Verdiendekking: Met zijn redelijk lage payout ratio ( 47.2% ) worden de dividendbetalingen van 1177 ruimschoots gedekt door de winst.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Met zijn lage cash payout ratio ( 18.4% ) worden de dividendbetalingen van 1177 goed gedekt door de kasstromen.


Ontdek bedrijven met een sterk dividend